Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Unknown 3

Sponsor Class

OTHER 4OTHER_GOV 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Adenomatous Polyposis Coli 2Surgical Wound Infection 1Rectal Neoplasms 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Erythromycin × Clear all
NCT03436719 2019-03-05

Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

State Scientific Centre of Coloproctology, Russian Federation

Phase NA Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection

NCT02354560 2015-02-03

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
15 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02175914 2014-06-26

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
20 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡